Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML

NCT05334693 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Belarusian Research Center for Pediatric Oncology, Hematology and Immunology